Table 1.
Characteristics of BC patients included in this study.
Variable | Overall set (n = 395) | Training set (n = 197) | Testing set (n = 198) | |
---|---|---|---|---|
Age (mean ± SD, years) | 67.82 ± 10.52 | 67.11 ± 10.36 | 68.53 ± 10.63 | |
Gender (n) | Male | 291 | 149 | 142 |
Female | 104 | 48 | 56 | |
Stage (n) | Stages I-II | 126 | 71 | 55 |
Stages III-IV | 267 | 126 | 141 | |
UA | 2 | 0 | 2 | |
T stage (n) | T0 | 1 | 0 | 1 |
T1-2 | 116 | 62 | 54 | |
T3-4 | 246 | 119 | 127 | |
UA | 32 | 16 | 16 | |
N stage (n) | N0 | 228 | 116 | 112 |
N1-3 | 126 | 56 | 70 | |
UA | 41 | 25 | 16 | |
M stage (n) | M0 | 189 | 105 | 84 |
M1 | 10 | 4 | 6 | |
UA | 196 | 88 | 108 | |
Survival time (mean ± SD, years) | 2.14 ± 2.23 | 2.12 ± 2.23 | 2.15 ± 2.23 | |
Risk scores (mean ± SD) | 1.61 ± 1.63 | 1.65 ± 1.86 | 1.56 ± 1.35 |
BC, bladder cancer; SD, standard deviation.